Pyxis Oncology
PYXS
PYXS
45 hedge funds and large institutions have $76.1M invested in Pyxis Oncology in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
62% less capital invested
Capital invested by funds: $200M → $76.1M (-$124M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
45
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.32M | |
| 2 | +$3.83M | |
| 3 | +$2.13M | |
| 4 |
Citigroup
New York
|
+$929K |
| 5 |
LCM
Laurion Capital Management
New York
|
+$232K |
Top Sellers
| 1 | -$4.39M | |
| 2 | -$3.42M | |
| 3 | -$2.74M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$1.93M |
| 5 |
PA
Perceptive Advisors
New York
|
-$1.68M |